Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2016-09-16
Buyer: Oslo Universitetssykehus HF [Oslo University Hospital]
Country: NO
Region: NORGE
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33100000
Estimated value: 2912500 

Technical requirements: New analysis machines shall be procured for Oslo University Hospital HF, Aker, The Medical Biochemistry Operational Division.
The Department of Medical Biochemistry (MBK) is a part of the Clinic for laboratory medicine (KLM) at Oslo University Hospital HF (OUS). The department consists of ten divisions and has 24 hour continual operation at four of the hospitals that merged to become OUS (Aker, Ullevål, The National Hospital [Rikshospitalet] and The Radium Hospital [Radiumhospitalet]. The analysis instruments at MBK/The Operational Division of Aker hospital, have been reported as broken down and new equipment must replace these. Joint methodology between the locations has greatly contributed to harmonisation of the results for the same analyses carried out at the different divisions. This is of great significance in achieving a single presentation of the laboratory results in a common electronic patient record for OUS and for interpretation of the results. The majority of analyses carried out in serum or plasma (clinical chemical analyses), utilise instruments using methods that are delivered by Roche Diagnostics Norge AS. There are some technical dependencies that are important with regard to new acquisitions. The most important requirements that form the basis for this procurement are listed below. — The same level of the analyses is of major significance for patient safety. o Analyses that build on immunological analyses principles are often not standardised and therefore one does not get analysis results of the same level. Immunological analyses are affected differently with heterogeneity in the tests and this can create major uncertainty with interpretation of individual tests both in the laboratory and in the clinic. o The alternative is to set up suitable lines in the result reports for ‘same analysis’ performed at different locations. In some circumstances this will require a substantial effort on the data side and almost certainly significant uncertainty on the clinic side regarding interpretation of the results. The results sheets will also in this case be extremely difficult to follow and difficult to navigate. Such an approach would also mean that one must discard the work now being done to get one encoder for analysis. — I.A. The cardiac markers have major method differences. o The cardiac markers: Troponin T and Troponin I. — Both are used to present i.a. diagnosis of heart attack. The analysis Troponin T which has good analytical sensitivity has been used throughout OUS for a long time. Since patients move between the OUS hospitals, it is important that there is one method and the same level of analyses used. Roche Diagnostics Norge AS is the only one that has this cardiac marker on it's large automatic analysis machines. The marker for heart failure (NT pro BNP) is also used amongst all of the OUS hospitals. Different suppliers offer either NT pro BNP or BNP to assess heart failure. The 2 analyses are not equal and it is also registered that the same test is analysed in different levels regarding NT pro BNP from different tenderers. — o The same level means that the laboratories at the different locations can be back-up for each other. o Comparable results when there is a need to move patients from 1 location to another. o Common encoder in the laboratory computer system. o The Aker Operational Division performs analyses of the municipal emergency day entry (KAD). The same level of analyses makes it easier to follow up patients when they are transferred from OUS to KAD. — A major advantage is that one replenish reagents on machines from Roche Diagnostics Norge AS while they are in operation. o The Aker Operational Division is the smaller division with 24 hour operation. Joint methodology with the other divisions means that the division can get support from a large group with high competence on the instrument and the analyses within the same department. The procurement will be carried out via a notice of intent. This is based on Roche Diagnostics Norge AS being the only supplier that can perform the delivery, due to technical reasons. The terms in FOA § 14-4 first section letter c. are therefore deemed to be fulfilled.